Безопасен ли retinoyl pentapeptide-4 при беременности?

Безопасные альтернативы retinoyl pentapeptide-4 при беременности | VeriMom

Related ingredients

Frequently asked questions

Безопасен ли retinoyl pentapeptide-4 при беременности?

No evidence in EU Cosmetics Annex II/III or harmonised CLP of reproductive hazards for palmitoyl pentapeptide‑4; regulatory/industry sources and ingredient databases list it as a signal peptide (Matrixyl) with no reproductive or teratogenic classification. Topical peptides have low but measurable dermal absorption, and palmitoyl conjugation increases lipophilicity and skin penetration modestly, so exposure is low but measurable in adults. Sources: EWG ingredient page; ingredient summaries (Paula's Choice) and peptide safety overview (CIR pentapeptides review).

Безопасен ли retinoyl pentapeptide-4 при грудном вскармливании?

Same rationale as pregnancy: no CMR or reproductive classifications and no published animal/human developmental or lactation toxicity for palmitoyl pentapeptide‑4. Topical exposure to parent peptide is low but measurable; transfer into breastmilk not reported. Evidence absence supports low hazard. (See same sources.)

Безопасен ли retinoyl pentapeptide-4 для кожи малыша?

No infant‑specific developmental or toxicity data were found. Because infant/young‑child skin has higher absorption (higher surface‑area:weight and immature barrier), increase exposure score by +1 over adult (adult e=1 → infant e=2). No data indicate increased hazard or specific mechanisms affecting development or endocrine systems for this peptide. Sources: peptide safety reviews and product/INCI descriptions.

Как VeriMom оценивает retinoyl pentapeptide-4?

VeriMom оценивает retinoyl pentapeptide-4 в 13/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы retinoyl pentapeptide-4 при беременности?

См. наш список безопасных альтернатив retinoyl pentapeptide-4 с аналогичной функцией и классификацией без известных рисков.